• Immunome, Inc. (NASDAQ:IMNM) Receives Consensus Rating of "Buy" from Analysts

    Source: Buzz FX / 07 Oct 2024 02:36:10   America/New_York


    Immunome, Inc. (NASDAQ:IMNM) Receives Consensus Rating of "Buy" from Analysts Written by MarketBeat October 7, 2024 Share Link copied to clipboard. Shares of Immunome, Inc. ( NASDAQ:IMNM - Get Free Report ) have been assigned an average rec
    Read more...
Share on,